Few studies exist exploring the discriminative stimulus effects of inhalants and none that have trained an interoceptive discrimination using the inhaled route. This study was designed to assess if it was possible to train an inhaled toluene discrimination. The second objective was to determine whether the discrimination was based on interoceptive or exteroceptive stimulus effects. Eight B6SJLF1/J mice were trained to discriminate 10 min of exposure to 6000 ppm inhaled toluene vapor from air, using a standard food-reinforced operant procedure. Toluene vapor produced robust, concentration-dependent, discriminative stimulus effects, with concentrations of 4000 ppm and higher producing full substitution. Substitution of inhaled toluene vapor for the training condition was exposure-time dependent. A minimum of 7 min of exposure to 6000 ppm was required to produce complete substitution. Injected intraperitoneal toluene produced dose-dependent full substitution for inhaled toluene vapor. Both inhaled and intraperitoneal ethylbenzene produced similar levels of partial substitution for 6000 ppm toluene vapor. Inhaled isoflurane vapor produced no substitution for toluene vapor. These results show that a toluene vapor discrimination can be successfully trained in mice and the discrimination is selective for toluene compared to ethylbenzene and isoflurane. The results also suggest that the discrimination was likely to have been based primarily on interoceptive rather than exteroceptive stimulus effects. Behavioural
Introduction
The abuse of inhalants is a serious social and medical problem both in the United States and worldwide. Although all age brackets report inhalant use, the prevalence of inhalant abuse is highest among children. The most recent data from the 2005 Monitoring the Future Study Survey found that 17% of eighth graders reported inhalant use at least once (Johnston et al., 2005) . Despite the magnitude of the problem, the neural basis for the abuse-related acute behavioral effects of inhalants are poorly understood, especially at the high concentrations at which they are typically abused (Balster, 1998) .
The subjective effects of inhalants are one important aspect of their pharmacology that may be related to their abuse potential (Balster, 1987) . Unfortunately, with the exception of anesthetic gases and volatile anesthetics, virtually all abused inhalants have known toxicity, especially at the high concentrations that are necessary to produce rapid, intoxicating effects. For instance, the OSHA ceiling air concentration at which the inhalant toluene is considered unsafe for any exposure duration is only 300 ppm (OSHA, 1998) which is near the lower limit for detectable behavioral effects in rodents after shortduration exposure Bowen and Balster, 1998) . Fortunately, the drug discrimination model in animals is highly predictive of a drug's subjective effects in humans and may therefore be an extremely useful surrogate for understanding the neurochemistry underlying this aspect of inhalants effects, much as has been the case for many other classes of abused drugs (Schuster and Johanson, 1988; Balster, 1991) .
Only two studies have trained inhalants themselves as an interoceptive discriminative stimulus and both of these experiments used intraperitoneal injections of the compound as a training stimulus, rather than administration via the route it is abused (i.e. inhalation). In the first of these studies, conducted in mice, 100 mg/kg intraperitoneal toluene was trained as a discriminative stimulus (Rees et al., 1987c) . Following training, substitution tests were conducted with inhaled toluene, intraperitoneal pentobarbital and intraperitoneal morphine. The results indicated that inhaled toluene concentrations of 1200 ppm and higher fully substituted for 100 mg/kg intraperitoneal toluene. Pentobarbital also fully substituted for intraperitoneal toluene, whereas morphine did not produce intraperitoneal toluene-like responding. In rats trained to discriminate 100 mg/kg intraperitoneal toluene from saline, inhaled toluene was not tested, but both methohexital and oxazepam produced only partial substitution for intraperitoneal toluene (Knisely et al., 1990) . In both of these studies, injected inhalants proved to be difficult to work with as training stimuli, owing to their tissue-damaging effects over repeated daily injection as well as an extremely lengthy training procedure. Further studies were never undertaken as a consequence (Balster, unpublished observation) .
Given the difficulties of injecting inhalants, and the fact that they are not commonly administered in that manner, the best route for examining the interoceptive discriminative stimulus effects of inhalants is probably by inhalation. Most of the technical difficulties associated with inhalational delivery, such as reproducibly producing and accurately measuring inhalant concentrations, choosing behaviorally active inhalant concentrations and assessing relevant exposure durations, have been overcome (Balster, 1987) . A few studies have utilized these techniques to test for cross-substitution of inhalants in animals trained to discriminate injected drugs from vehicle. The general conclusion of these experiments is that a subset of inhalants have discriminative stimulus effects that share some similarity to ethanol, benzodiazepines and barbiturates (Rees et al., 1987a, b; Bowen and Balster, 1997; Bowen SE et al., 1999; Shelton and Balster, 2004) . The data from these cross-substitution studies are valuable and suggest that GABA A -receptor positive modulation and perhaps, to a lesser degree, NMDA receptor antagonism may play a role in the discriminative stimulus effects of inhalants. However, there are reasons to hypothesize testing inhalants in animals trained to discriminate other drugs from vehicle may alone be insufficient to completely characterize the discriminative stimulus effects of inhalants.
In many respects, the discriminative stimulus effects of the few inhalants that have been examined to date bear considerable similarity to ethanol (Grant, 1994 (Grant, , 1999 ). Ethanol's discriminative stimulus has been repeatedly shown to be a mixed stimulus composed of strong GABApositive modulator and NMDA antagonist-like effects, as well as some less pronounced serotonergic effects (Grant et al., 1991 (Grant et al., , 1997 Sanger, 1993; Shelton and Balster, 1994; Shelton, 2004) . Given the proper training procedure, any of these three components of ethanol's mixed stimulus is sufficient to elicit full substitution in ethanol-trained animals. For example, any of a number of GABA-positive modulators and NMDA antagonists will completely substitute in animals trained to discriminate ethanol from vehicle (De Vry and Slangen, 1986; Kostowski and Bienkowski, 1999; Shelton and Grant, 2002) . When ethanol, however, is tested in animals trained to discriminate those same GABA-positive modulators or NMDA antagonists from vehicle, ethanol produces little if any substitution (Herling et al., 1980; De Vry and Slangen, 1986; Balster et al., 1992; Butelman et al., 1993) . This unique pattern of results has been termed asymmetric or asymmetrical substitution. If inhalants also produce what is effectively a mixed discriminative stimulus resulting from effects at multiple receptors, as seems likely on the basis of the available data, they too may have asymmetrical substitution profiles, and therefore the only means of completely unraveling their discriminative stimulus effects would be by training the inhalants themselves as discriminative stimuli.
Another concern with training inhalants as discriminative stimuli is their pronounced odor and local irritant properties. When the drug-discrimination paradigm was first being differentiated from the state-dependent learning field, it was unclear whether the discriminative stimulus effects of injected drugs that could control behavior were based on central nervous system (CNS) activity or on these exteroceptive stimulus effects. A number of studies conducted in the 1970s and 1980s consistently showed that the discriminative stimulus effects of injected drugs, even those that possess exteroceptive stimulus effects, were almost certainly on the basis of the drug's activity in the CNS rather than peripheral cues such as change in heart rate (Kubena and Barry, 1969; Schechter and Rosecrans, 1971; Schechter, 1973; Johansson and Jarbe, 1976) . These studies, and others, showed that, in the absence of strong peripheral cues, interoceptive cues of injected drugs play a primary role in controlling behavior. Inhalants, however, present a unique challenge in drug discrimination research because they have very pronounced odors and local irritant effects even at concentrations that are likely to be well below those that produce behavioral effects on measures such as locomotor performance (Moser and Balster, 1986; Bowen and Balster, 1998) . As such, either the interoceptive or the exteroceptive cues of inhalants could potentially be used to direct behavior and one component, if of sufficient intensity, might overshadow the weaker component.
A few studies have explicitly examined the consequences of exteroceptive and interoceptive stimulus compounding in drug discrimination (see Jarbe et al., 1989 for review) . In one rodent study, exteroceptive visual + tactile cues combined with interoceptive drug cues produced by D-amphetamine were trained versus the same visual + -tactile cues combined with pentobarbital (Duncan, 1986) . One group of rats was trained with high drug doses; in a second group of rats the training drug doses were relatively low. The visual + tactile stimuli were identical in both groups. The study found that both interoceptive and exteroceptive cues could control behavior. When the drug training doses were high, however, the rats attended more strongly to the interoceptive drug cues and when the training drug doses were low, the rats attended more strongly to the exteroceptive visual + tactile cues. These data indicate that when a compound cue composed of an interoceptive drug stimulus and an exteroceptive stimulus are combined, the discrimination learned is based on the relative salience of the interoceptive versus exteroceptive cues.
If the interoceptive cues are of sufficient intensity they will not be overshadowed and alone will be capable of controlling behavior. If the interoceptive stimuli, however, are weak relative to the exteroceptive stimuli they will control behavior less strongly (Jarbe et al., 1989) .
The first goal of the present experiment was to determine if a prototypic abused inhalant, toluene, could be trained as a discriminative stimulus via its commonly abused inhalation route. As compounds with strong odors can easily be trained as discriminative stimuli in rodents, the ability to train such a discrimination was not really in doubt (Bodyak and Slotnick, 1999) . The second and more critical goal of this study was to determine what aspect of toluene's discriminative stimulus, its interoceptive effects, exteroceptive stimulus properties or both were responsible for maintaining the discrimination.
Methods

Subjects
Eight B6SJLF1/J mice (Jackson Laboratory, Bar Harbor, Maine, USA) served as subjects. This strain is an F1 hybrid derived from C57BL6/J female and SJL/J male parents, which has been used previously in our laboratory for drug discrimination studies . The mice were 9-10 weeks old at the start of discrimination training. The mice were individually housed on a 12 h light/dark cycle (lights on 07:00 h) and allowed to acclimate to the laboratory for a period of one week before the start of training. To promote operant responding, the mice were fed 3-5 g of standard rodent chow (Harlan, Teklad, Madison, Wisconsin, USA) once daily after the daily test session. Feeding was adjusted to maintain a healthy, stable weight of between 25 and 31 g for the duration of the study. Feeding was increased if the animals showed any signs of adverse consequences resulting from this mild food restriction.
Apparatus
Drug discrimination sessions were conducted in standard mouse operant conditioning chambers (Med-associates model ENV-307AW, St. Albans, Vermont, USA). Each chamber was equipped with two ultrasensitive optically switched levers (Med-associates model ENV-310M) on the front wall. Above each lever was a yellow lightemitting-diode stimulus lamp. Equidistant between the levers was a recessed receptacle into which a 0.1-ml liquid dipper cup could be elevated via an electrically operated dipper mechanism. A single 5-W houselight was located at the top center of the chamber rear wall. The operant conditioning chambers were individually housed in sound-attenuating and ventilated cubicles. Drug discrimination schedule conditions and data recording were accomplished using a Med-associates interface and Med-PC version 4 control software running on a PC-compatible computer (Med-Associates, St. Albans, Vermont, USA). The milk solution reinforcer consisted of 25% sugar, 25% nonfat powdered milk and 50% tap water (by volume).
The static vapor chambers and general procedures used to expose the mice to toluene vapors before drug discrimination testing have been described in detail in many reports (e.g. Balster, 1996, 1997) . Briefly, each chamber consisted of a 26-l cylindrical glass bell jar with a clear acrylic lid with an attached fan motor. A foam rubber gasket was fixed to the rim of the bell jar to insure a tight seal. A drive shaft with sealed bearings extended through the lid into the chamber where it was connected to a plastic fan blade. Directly below the fan blade was a suspended wire mesh platform to which a filter paper disk was attached. Toluene and ethylbenzene vapor were produced by injecting liquid onto the filter paper using a gas-tight glass microliter syringe. The internal fan was then activated which rapidly volatilized the liquid and produced vapor. As the inhalation chambers were sealed and of a fixed volume, the amount of liquid necessary to produce a given vapor concentration could be calculated accurately using the ideal gas law equation for room temperature (Nelson, 1971 ). It was not deemed necessary to make any temperature or atmospheric pressure corrections to the calculations since normal laboratory variability in these factors were predicted to have a 1% or less effect on the parts per million of vapor produced by a given volume of liquid toluene or ethylbenzene. The rise time and stability of chamber toluene vapor concentrations were verified before the start of the study by using a vacuum pump to recirculate the chamber air/toluene vapor mixture through a single wavelength monitoring infrared spectrometer set at 13.9 mm (Miran 1A, Foxboro Analytical, North Haven, Connecticut, USA).
Before vapor exposure, each mouse was weighed and placed into a separate, ventilated, 7.5 cm diameter Â8 cm tall, cylindrical stainless steel container (Oneida, Oneida, New York, USA). The stainless steel containers were then inserted into the inhalation chamber and the lid sealed. The calculated volume of liquid to produce a given chamber concentration was injected via a stoppered port in the chamber lid onto the filter paper. The fan was then activated, which rapidly volatilized the liquid and distributed the vapor throughout the chamber. Air exposure sessions were identical to those with vapor except that no liquid toluene or ethylbenzene were injected into the chamber.
Discrimination training
After the animals were acclimated to the laboratory, daily (M-F) 15-min training sessions were initiated. The mice were first trained to press one lever under a fixed ratio 1 response (FR 1) schedule. Upon completion of the FR requirement, a 0.1-ml liquid dipper cup was elevated into the dipper receptacle for 3 s. Responses occurring while the dipper was elevated did not count toward completion of the next ratio requirement. Responding on the inactive lever reset the FR requirement on the correct lever. The animals were then trained to respond on the opposite lever under the FR 1 schedule. During experimental sessions, both stimulus lights and the house light were illuminated for the duration of the session. Once the animals were reliably responding at FR 1 during the 15-min session, the operant session length was decreased to 5-min in duration and behavior was again allowed to stabilize before drug discrimination training sessions were initiated. During each 5-min discrimination training session, one of the two levers was designated as correct. The correct lever was determined by whether the subject received a 10-min exposure to 6000 ppm toluene vapor or an identical 10-min exposure in the inhalation chamber to air. Completion of the FR requirement on the correct lever resulted in 3 s of dipper availability. The lever corresponding to toluene vapor and air exposure remained fixed for the duration of the study for a given animal but was counterbalanced across mice. Exposures were presented according to a double alternation schedule (i.e. two toluene vapor days followed by two air days). Responses emitted on the incorrect lever were recorded and reset the FR requirement on the correct lever. Over the course of 10-20 sessions, the response requirement was increased to FR 12. These training conditions were in effect for the remainder of the study. Animals were determined to have acquired the 6000 ppm toluene vapor and air discrimination when the first FR was completed on the correct lever, before the completion of a FR on the incorrect lever, in eight out of 10 consecutive sessions. Additionally, the mice were required to emit greater than 80% of responses on the correct lever during all 10 of these sessions.
Substitution test procedure
Following acquisition of the 6000 ppm toluene vapor and air discrimination, substitution tests were conducted on Tuesday and Friday, providing that the mice continued to exhibit accurate stimulus control on the Monday, Wednesday and Thursday training sessions. Test sessions were suspended if an animal did not emit the first FR on the correct lever and produce greater than 80% correctlever responding during all training sessions since the last test session. If a mouse did not meet the criteria for testing on a particular Tuesday or Friday, it received additional daily toluene vapor and air training sessions until the correct first FR, as well as greater than 80% correct-lever responding, was emitted for a minimum of three consecutive training sessions at which point it was again returned to the Tuesday and Friday testing, Monday, Wednesday, Thursday training schedule. Between substitution tests, the double alternation sequence of toluene vapor and air training sessions was continued.
Substitution tests with toluene, ethylbenzene and isoflurane vapor, except those assessing exposure duration, were preceded by a 10-min exposure to a single concentration of vapor. The animal was then immediately removed from the exposure chambers and placed into the operant chamber for a 5-min drug discrimination test session. Substitution test sessions examining injected toluene or ethylbenzene were initiated by a toluene/ Liposyn or ethylbenzene/Liposyn injection, followed by a 10-min air exposure period in the vapor chamber and a subsequent 5-min substitution test session. The control test for injected toluene or ethylbenzene was intraperitoneal Liposyn vehicle, a 10-min air exposure and a 5-min substitution test. On test days, both levers were active and completion of an FR requirement on either lever resulted in dipper presentation. Vapor concentrations or injections were administered in an ascending order. Each condition was tested once without regard for the prior days training condition (toluene vapor or air). Before each concentration or dose-effect curve control test sessions were conducted with 6000 ppm toluene vapor and air.
Drugs
HPLC grade toluene and ethylbenzene were purchased from Aldrich Chemicals (Milwaukee, Wisconsin, USA). Isoflurane, USP (Isoflo) was purchased from Abbott Laboratories (North Chicago, Illinois, USA). For injection, toluene and ethylbenzene was suspended in Liposyn II -20% fat emulsion (Abbott Laboratories) to produce a constant injection volume of 10 ml/kg of body weight. The toluene/Liposyn and ethylbenzene/Liposyn suspension was vortexed for 30 s immediately before being drawn into a syringe and rapidly injected.
Data analysis
Toluene vapor and air-lever responses and dipper presentations were recorded for each animal. Group means ( ± SEM) were calculated for both percentage toluene vapor and air-lever responding and response rate at each drug dose or concentration. During drug discrimination tests, the percentage of responses emitted on the toluene vapor-appropriate lever during the entire test session and lever on which the first fixed ratio (FFR) was completed were used as measures of the ability of a test condition to substitute for the 6000 ppm toluene vapor training concentration. The FFR was defined as the first lever upon which an individual animal completed a consecutive FR12. FFR data were expressed as number of mice responding on the toluene lever compared to total number of mice that completed at least one consecutive fixed-ratio value. Any vapor concentration or injected dose that suppressed response rates to the extent that the animal did not complete an FFR resulted in the exclusion of that mouse's data point from the group leverselection and FFR analysis, although that animal's data were included in the response rate determination. The response rate for each test concentration or dose was expressed in responses/second. A criterion of 80% or greater toluene vapor-appropriate responding was selected to indicate full substitution for the 6000 ppm toluene vapor training concentration. Mean toluene vapor-lever responding between 20 and 79% was defined as partial substitution. Mean toluene vapor-lever responding of less than 20% was considered to be evidence of no substitution for 6000 ppm toluene vapor. When possible, EC 50 and ED 50 values (and 95% confidence limits) for 6000 ppm toluene vapor-lever selection were calculated based on the linear portion of each mean dose-effect curve. Calculations were performed using a Microsoft Excel spreadsheet on the basis of SAS Pharm/PCS version 4 (Tallarida and Murray, 1986) .
Results
At the outset of the study, the time necessary to reach chamber concentration equilibrium following liquid toluene introduction as well as static chamber integrity were assessed. IR spectrometer absorbance values for 1000, 2000, 4000 and 6000 ppm toluene vapor over 10 min are shown in Fig. 1 . Chamber absorbance was approximately proportional to toluene liquid injection volume and IR absorbance values were nearly identical to those reported in an earlier study (Moser and Balster, 1981) . Vapor concentrations reached peak levels within the first minute after activating the internal fan (Fig. 1 inset) and remained stable for at least 10 min at all four concentrations. Figure 2 shows group discrimination accuracy as a function of training days. Animals were considered to respond correctly only if they emitted both a correct first FR and greater than 80% correct-lever responding for the entire session. Data are shown as 2-day group means for a given training stimulus (air or toluene vapor). Overall accuracy increased across test sessions in a similar linear pattern for both air and toluene vapor. It required a mean of 10 air training sessions and 14 toluene vapor training sessions before greater than 80% of mice met this daily criterion on any given pair of same-condition training days. All eight mice acquired the 6000 ppm toluene vapor versus air discrimination. A mean of 25.9 ± 2.8 total training sessions (19-44 session range) were required to reach overall acquisition criteria of eight out of 10 consecutive sessions of successfully meeting the daily correct responding criteria.
The upper panel of Fig. 3 (filled squares/solid line) shows the concentration-effect curve for substitution of increasing concentrations of toluene vapor for the 6000 ppm toluene vapor training concentration. The FFR emitted on the toluene-appropriate lever for each concentration of inhaled toluene is shown in Table 1 . Toluene vapor concentration-dependently substituted for the 6000 ppm training concentration with an EC 50 value of 1792 ppm (CL: 1459-2200 ppm). The 500 and 1000 ppm toluene vapor concentrations produced less than 20% toluene- IR spectrometer plot showing exposure chamber air absorbance over a 10-min period following injection of liquid toluene volumes calculated to produce 1000, 2000, 4000 or 6000 ppm toluene vapor. Inset shows chamber air absorbance for 70 s following the injection of liquid toluene calculated to produce 6000 ppm toluene vapor. Arrows mark the time at which toluene was injected as well as the time the internal fan was engaged. appropriate responding with only one of eight mice emitting their FFR on the toluene lever at the 1000 ppm concentration (Table 1 ). The 2000 ppm toluene vapor concentration produced 57% toluene-appropriate responding with four of eight mice emitting their FFR on the toluene-appropriate lever. Toluene vapor concentrations of 4000, 6000, 8000, 10 000 and 12 000 ppm produced full substitution for the 6000 ppm toluene vapor training concentration. Six of eight mice emitted their FFR on the toluene lever at the 4000 ppm concentration and eight of eight mice emitted their first FFR on the toluene lever at 6000 ppm and greater.
The upper panel of Fig. 3 (open circles/dashed line) also shows the substitution of increasing doses of intraperitoneal injected liquid toluene for the 6000 ppm toluene vapor training condition. Like toluene vapor, intraperitoneal liquid toluene produced dose-dependent substitution for the toluene vapor training condition with an ED 50 value of 344 mg/kg (CL: 298-399 mg/kg). The 100 mg/kg intraperitoneal dose produced no toluene vapor-lever responding nor did any mice emit their FFR on the toluene-appropriate lever (Table 1 ). The 300 mg/kg dose produced 36% toluene-lever responding with three of eight mice emitting their FFR on the toluene-appropriate lever. The 560 mg/kg dose produced 99% toluene vaporlever responding with seven of eight mice emitting their FFR on the toluene-appropriate lever. An even greater dose of 720 mg/kg liquid toluene resulted in a decline to 67% in toluene vapor-appropriate responding with FFR being emitted on the toluene lever in six of the seven mice that completed at least one fixed ratio at that dose. The four leftmost points in the upper panel of Fig. 3 are control test sessions conducted before each test curve. Control tests following 10 min of exposure to air or air + the intraperitoneal toluene vehicle (first and second open circles, respectively) produced no toluene-vaporappropriate responding or FFR responses on the tolueneappropriate lever. Control tests following exposure to 6000 ppm toluene vapor or 6000 ppm toluene vapor + the intraperitoneal toluene vehicle (first and second filled squares, respectively) resulted in almost 100% toluene vapor-lever responding with all (eight of eight) mice emitting their FFR on the toluene-appropriate lever in both cases. The data show the number of animals emitting their first fixed ratio (FFR) on the toluene-appropriate lever (first number) compared with the number of animals completing at least one full fixed ratio (second number). Data are shown for inhaled toluene, ethylbenzene and isoflurane as well as intraperitoneal injected toluene and ethylbenzene.
The lower panel of Fig. 3 (filled squares/solid line) shows operant response rates following 10-min of exposure to increasing concentrations of toluene vapor. Up to the highest test concentration of 12 000 ppm there were no pronounced changes in response rates in the 5-min test session. This was despite visible ataxia as well as overt signs of respiratory tract irritation such as profuse lacrimation and salivation noted during the transfer of the mice from the vapor exposure chamber to the operant test chamber after exposure to the highest concentration. For these reasons, additional higher toluene concentrations were not examined. The lower panel of Fig. 3 (open circles/dashed line) also shows the effects of increasing intraperitoneal injected doses of toluene on rates of operant responding. As was the case with toluene vapor, intraperitoneal toluene up to a dose of 720 mg/kg did not have substantial effects on rates of operant responding, although there was a slight trend for decreased responding as dose increased. Higher concentrations of liquid toluene above 720 mg/kg were not examined, as maximal toluene-vapor-appropriate responding was generated at the lower 560 mg/kg dose and 720 mg/kg liquid toluene resulted in overt signs of local irritation in the animals (vocalizations and writhing) immediately after injection. Mean response rates during control test sessions following air, air + intraperitoneal injection vehicle, 6000 ppm toluene and 6000 ppm toluene + intraperitoneal injection vehicle ranged from 1.04 responses/s in the air control session to 1.39 responses/s in the 6000 ppm toluene + intraperitoneal vehicle control session (Fig. 3 , bottom panel, first four points). Mean reinforcers earned per session ranged from a low of 26 in the air control session to a high of 36 in the 6000 ppm toluene + intraperitoneal vehicle control session.
The upper panel of Fig. 4 (filled squares/solid line) shows the concentration-effect curve for substitution of increasing concentrations of ethylbenzene vapor for the 6000 ppm toluene vapor training concentration. Ethylbenzene vapor produced concentration-dependent partial substitution for the 6000 ppm toluene vapor training concentration. Ethylbenzene concentrations of 500-6000 ppm produced less than 20% toluene-appropriate responding. The 1000 and 2000 ppm ethylbenzene concentrations resulted in zero of eight mice emitting their FFR on the toluene-appropriate lever (Table 1) . The 4000 and 6000 ppm ethylbenzene concentrations resulted in one of eight and three of eight mice emitting their FFR on the toluene lever, respectively. The 8000 ppm ethylbenzene vapor concentration produced 52% toluene-appropriate responding with six of eight mice emitting their FFR on the toluene-appropriate lever. Ethylbenzene vapor concentrations of 10 000 and 12 000 ppm produced 66 and 62% toluene-appropriate responding, respectively. At the 10 000 ppm ethylbenzene concentration, seven of eight mice emitted their FFR on the toluene lever, whereas at the 12 000 ppm concentration five of eight mice emitted their FFR on the toluene lever. The upper panel of Fig. 4 (open circles/dashed line) also shows the substitution of increasing doses of intraperitoneal injected liquid ethylbenzene for the 6000 ppm toluene vapor training condition. Like ethylbenzene vapor, intraperitoneal ethylbenzene produced dose-dependent partial substitution for the toluene vapor training condition. The 100 and 300 mg/kg intraperitoneal doses produced no substitution for toluene vapor with no mice emitting their FFR on the toluene lever at the 100 mg/kg dose and only one of eight mice emitted their FFR on the toluene lever at the 300 mg/kg dose. The 560 mg/kg ethylbenzene dose produced 40% toluene lever responding and four of eight mice making their FFR on the toluene lever. The 720 mg/kg dose produced 58% toluene-vapor-lever responding and three of five mice emitting their FFR on the toluene lever.
The four leftmost points in the upper panel of Fig. 4 are control test sessions conducted before each test curve. Control tests following 10-min of exposure to air or air + the intraperitoneal injection vehicle (first and second open circles, respectively) produced no substitution for 6000 ppm toluene vapor. Control tests following exposure to 6000 ppm toluene vapor (filled square) or 6000 ppm toluene vapor + intraperitoneal injection vehicle (first and second filled squared, respectively) resulted in full substitution for 6000 ppm toluene vapor. FFR responses also demonstrated good stimulus control with all the mice emitting their FFR on the air lever following air and air + intraperitoneal vehicle exposure and the toluene lever following toluene and toluene + intraperitoneal vehicle exposure.
The lower panel of Fig. 4 (filled squares/solid line) shows operant response rates following 10-min of exposure to increasing concentrations of ethylbenzene vapor. The highest test concentration of 12 000 ppm ethylbenzene vapor resulted in a mean 5-min response rate, which was 65% of the air control value. Visible ataxia as well as overt signs of respiratory tract irritation (profuse lacrimation and salivation) were also noted during the transfer of the mice from the vapor exposure chamber to the operant test chamber after exposure to the highest concentration. For these reasons, higher ethylbenzene concentrations were not examined. The lower panel of Fig. 4 (open circles/dashed line) also shows the effects of increasing intraperitoneal injected doses of ethylbenzene on rates of operant responding. The 720 mg/kg intraperitoneal dose of ethylbenzene produced responses rates that were 54% of those following the air + intraperitoneal vehicle control session. Higher concentrations of intraperitoneal ethylbenzene above 720 mg/kg were not examined since, as was the case with 720 mg/kg intraperitoneal toluene, it produced signs of distress immediately after injection.
Response rates during control test sessions following air, air + intraperitoneal injection vehicle, 6000 ppm toluene and 6000 ppm toluene + intraperitoneal injection vehicle are also shown (Fig. 4 , lower panel, first four points).
The upper panel of Fig. 5 (filled squares/solid line) shows the concentration-effect curve for substitution of increasing concentrations of isoflurane vapor for the 6000 ppm toluene vapor training concentration. Isoflurane concentrations of 500-10 000 ppm were examined.
With the exception of one animal each at the 6000 and 8000 ppm concentrations, none of the mice emitted their first FR on the toluene lever following any isoflurane exposure concentration. The lower panel of Fig. 5 (filled squares/solid line) shows response rates following isoflurane exposure. The higher isoflurane concentrations produced a concentration-dependent reduction in response rates. The uppermost, 10 000 ppm isoflurane concentration, reduced response rates to 0.81 resp/s compared with a response rate of 1.45 resp/s in the air exposure control session.
The results of substitution tests following increasing exposure durations to the 6000 ppm toluene vapor training stimulus are shown in Fig. 6 (filled squares/ solid line). Numbers of mice emitting their FFR on the toluene-appropriate lever compared to the total number of mice tested at each exposure duration are shown in parentheses. Tests were conducted at 1-, 3-, 7-and 10-min after the beginning of toluene vapor exposure. At the exposure test duration of 1-min, toluene vapor failed to substitute for the training stimulus (10-min of exposure to 6000 ppm toluene vapor) producing 15% toluene-lever responding with only one of seven mice emitting their FFR on the toluene lever. Partial substitution of 68% toluene-lever responding was produced by the 3-min vapor exposure duration with five of seven mice emitting their FFR on the toluene-appropriate lever. Full substitution was produced by both the 7-and 10-min toluene-vapor exposure durations with seven of seven and six of seven mice emitting their FFR on the toluene lever, respectively. Control tests with 10-min of exposure to air (open circle) and 10 min of exposure to 6000 ppm toluene vapor (filled square) are shown as the left two points in Fig. 5 and resulted in 0 and 100% toluene lever responding, respectively. No exposure duration had any pronounced effect on rates of operant responding (data not shown).
Discussion
The results of this study indicate that exposure to 6000 ppm toluene vapor versus air can be readily trained as a discriminative stimulus in B6SJLF1/J mice. The discriminative stimulus effects of inhaled toluene vapor were orderly and concentration dependent across a wide range from 500 to 12 000 ppm (see Fig. 3 , filled squares/ solid line). Complete substitution for the 6000 ppm toluene vapor-training condition was generated by concentrations of 4000 ppm toluene and greater. This pattern of results is similar to that seen in scores of drug discrimination studies using injected or orally administered drugs in that the percentage drug lever responding increases directly with dose, peaking at or near the training dose.
Exposure to 6000 ppm for comparable durations to that used in this study produces locomotor incoordination and enhances locomotor activity in mice (Moser and Balster, 1985; Bowen and Balster, 1998) . It also has been shown to strongly suppress operant response rates in mice (Moser and Balster, 1986; Bowen and Balster, 1998) . We chose to use this relatively high concentration of toluene as a training stimulus to maximize the chance of successful acquisition as it has been shown that high drug doses are more easily trained as discriminative stimuli than low drug doses (e.g. Bowen SE et al., 1999) . A mean of only 26 training sessions was necessary to reach acquisition criteria, substantially shorter than the 51 sessions required to train a 1.5 g/kg intraperitoneal ethanol versus saline discrimination in the same strain of mice using comparable training conditions . It was also far shorter than the 35-100 day range needed to train a discrimination of 100 mg/kg intraperitoneal toluene in Swiss-Webster mice (Rees et al., 1987c) as well as the 121 mean sessions required to train a 100 mg/kg intraperitoneal toluene discrimination in rats (Knisely et al., 1990) . The shorter training period suggests that the discriminative stimulus effects of 6000 ppm inhaled toluene are more pronounced than the discriminative stimulus effects of the 100 mg/kg intraperitoneal dose previously trained in mice and rats (Overton et al., 1986) . This interpretation is strengthened by the fact that it required an intraperitoneal dose of 560 mg/kg toluene to fully substitute for the 6000 ppm training concentration this study. In contrast, it only required 1200 ppm toluene vapor to fully substitute for the 100 mg/kg intraperitoneal toluene training dose in the prior experiment in mice. It is interesting to note that in this study inhaled concentrations of toluene up to 12 000 ppm produced very little effect on operant performance. This could suggest that tolerance occurred to the rate-suppressing effects of toluene, but could also be due to the use of a different strain of mice than that used in the earlier studies (Moser and Balster, 1986; Bowen and Balster, 1998) . Additional experiments specifically designed to examine tolerance to the response-rate-suppressing effects of toluene vapor in B6SJLF1/J mice would be necessary to address this question.
The data from the toluene vapor concentration-effect curve are consistent with two alternative hypotheses. The Mean exposure time-effect curve for seven mice trained to discriminate 10-min of exposure to 6000 ppm inhaled toluene vapor from 10-min of exposure to air. Mean ( ± SEM) percentage inhaled toluene-lever responding as a function of exposure time to 6000 ppm toluene vapor is shown by the filled squares and solid line. Open circle above Air and filled square above Tol represent the results of control test sessions which were preceded by 10-min of air or 6000 ppm toluene vapor exposure, respectively. Numbers in () indicate the number of animals in the group emitting their FFR on the toluene-appropriate lever. first is that the discriminative stimulus effects of inhaled toluene vapor are controlled by CNS mechanisms, as is the case with most other drugs (Colpaert, 1999) . The second hypothesis is that the odor cues of toluene were responsible for maintaining the discrimination and, as the odor of the test concentration of toluene more closely matched that of the training concentration, the degree of substitution also increased. Olfaction in mice is highly developed and has long been know to be used for many natural discriminations, such as differentiating between related individuals and searching for food (Bowers and Alexander, 1967; Howard et al., 1968) . In addition, mice can be readily trained to discriminate between different odors, including differentiating between the odor of toluene (also know as methyl benzene) and benzene (Bodyak and Slotnick, 1999) . If the mice were simply discriminating the odor of toluene versus its absence, the inhalation discrimination would have little utility for examining the neurochemical processes underlying the CNS effects of toluene, which are unlikely to be mediated predominantly by olfactory mechanism. For this reason, several additional test curves were conducted. In the first of these, the ability of intraperitoneal injected toluene to substitute for the 6000 ppm inhaled toluene vapor training stimulus was examined (Fig. 3 , open circles/dashed line). Injected toluene dose-dependently substituted for 6000 ppm inhaled toluene vapor. Full substitution was produced at the 560 mg/kg intraperitoneal toluene dose. Some percentage of injected toluene absorbed by the bloodstream would be expelled as vapor in exhaled air similar to that which occurs when ethanol vapor is expelled during exhalation after oral or intravenous administration (Subramanian et al., 2002) , but it is uncertain if this expelled toluene vapor would be sufficient to produce an odor stimulus similar to the fairly high 6000 ppm toluene vapor concentration. Regardless the intraperitoneal substitution results do show that the discrimination is not dependent upon route of inhalant administration.
To determine the specificity of the inhaled toluene cue and further address the question of odor as a potential exteroceptive cueing mechanism, concentration/doseresponse curves were conducted for both inhaled and intraperitoneal ethylbenzene as well as inhaled isoflurane. Ethylbenzene is also a component in abused inhalant mixtures and is closely structurally related to toluene, whereas isoflurane is a more structurally dissimilar halogenated ether. Inhaled ethylbenzene vapor produced a maximum of 66% toluene-lever responding at the 10 000 ppm concentration, whereas isoflurane showed almost no substitution for toluene vapor at any concentration tested. Emerging evidence exists that inhalants as well as volatile anesthetics differ in the degree to which they will modulate receptor function (Cruz et 2006), so it is a plausible hypothesis that the disparity in the discriminative stimulus effects of toluene and isoflurane were due to differences in neurotransmitter receptor interactions. It is less certain if less pronounced structural differences between aromatic hydrocarbons alter their pharmacological mechanisms of action to the degree suggested by the ethylbenzene substitution results. Additional substitution tests with other aromatic hydrocarbons will be necessary to more conclusively answer this question.
Alternatively, it might simply have been the case that the distinct odors of the three compounds were responsible for the differences observed in substitution for toluene vapor. The similar levels of partial substitution produced by intraperitoneal injected ethylbenzene and inhaled ethylbenzene make that interpretation somewhat less likely but still not certain. Therefore, in a final test to examine the potential role of odor in producing toluene's discriminative stimulus effects, a toluene exposure time curve was conducted (Fig. 6 ). Mice were exposed to 6000 ppm toluene vapor for increasing durations before a standard 5-min discrimination test session. It was hypothesized that if odor was serving as the discriminative stimulus controlling behavior, even a brief exposure to 6000 ppm toluene vapor would be sufficient to elicit toluene-appropriate responding. Initial examination of chamber toluene vapor concentrations ascertained that 1-min was the minimum time required to fully volatilize a volume of liquid toluene that was calculated to produce a 6000 ppm vapor concentration (see Fig. 1 ). Mean toluene-lever responding following this 1-min exposure was less than 20%. As brief exposure was not sufficient to generate substantial toluene-lever responding, the data did indicate that 3 min of exposure to 6000 ppm toluene vapor produced 68% toluene-lever responding and 7-min of exposure produced full substitution for the 10-min training exposure duration. This is probably not surprising given that volatile vapors are quite quickly absorbed into the bloodstream. In one study with the vapor, 1,1,1-tricholoroethane, blood and brain inhalant concentrations of between 75 and 100% of maximal achievable levels for a wide range of 1,1,1-trichloroethane concentrations were reached in the shortest measured time-point of 6-min (Warren et al., 2000) . In addition, the results from the initial inhaled toluene concentration effect curve indicated that 4000 ppm toluene vapor resulted in complete substitution, suggesting that somewhat lower levels of toluene exposure are sufficient to produce discriminative stimulus effects indistinguishable from the 6000 ppm training condition. Individually, these tests do not conclusively prove that odor played no role in the toluene vapor versus air discrimination, but in aggregate they strongly suggest that the discrimination was based on CNS-mediated stimulus effects rather than olfaction or other exteroceptive stimulus mechanisms.
Overall, these experiments indicate that drug discrimination studies using inhalants as training stimuli may be a viable method for exploring the neurochemical substrates underlying the discriminative stimulus effects of these compounds. Additional studies using representative test drugs with known receptor mechanisms will be necessary to determine the neurochemical systems responsible for the discriminative stimulus effects of toluene. Studies examining inhalants other than ethylbenzene and isoflurane in animals trained to discriminate toluene vapor may also prove a valuable means to classify inhalants on the basis of the their behavioral effects and perhaps predict if they possess toluene-like abuse liability.
